绿康生化(002868) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was ¥141,922,869.97, a decrease of 11.52% compared to ¥160,395,845.10 in the same period last year[5] - The net loss attributable to shareholders was ¥29,408,859.45, showing an improvement of 6.17% from a loss of ¥31,342,797.54 in the previous year[5] - The company's basic and diluted earnings per share improved to -¥0.19, a 5.00% increase from -¥0.20 in the same period last year[5] - The company reported a net loss of ¥29,313,726.17 for the current period, an improvement from a net loss of ¥31,573,220.52 in the previous period, representing a decrease in loss of approximately 7.2%[22] - Operating profit was recorded at -¥30,374,532.03, compared to -¥39,561,575.59 in the previous period, indicating a significant reduction in operating losses by about 23.5%[22] - The company’s total comprehensive income for the period was -¥29,313,726.17, compared to -¥31,573,220.52 in the previous period, showing a reduction in comprehensive losses of approximately 7.2%[22] Cash Flow and Assets - The net cash flow from operating activities increased significantly to ¥32,909,805.04, a 315.89% improvement from -¥15,243,576.62 in the same period last year[5] - Cash flow from operating activities generated a net inflow of ¥32,909,805.04, a turnaround from a net outflow of -¥15,243,576.62 in the previous period[23] - Total cash and cash equivalents at the end of the period stood at ¥12,330,079.08, down from ¥68,380,217.19 at the end of the previous period, reflecting a decrease of approximately 82%[24] - The company’s cash and cash equivalents decreased significantly to CNY 12,330,079.08 from CNY 24,799,981.20, a decline of 50.3%[19] - The company’s investment activities resulted in a net cash outflow of -¥18,214,802.02, an improvement from -¥55,089,070.36 in the previous period[23] Liabilities and Equity - Total assets at the end of the reporting period were ¥1,444,745,643.94, down 3.15% from ¥1,491,670,606.60 at the end of the previous year[5] - The company’s total liabilities decreased by 125.95%, with shareholders' equity at -¥55,439,382.62 compared to -¥24,536,065.37 at the end of the previous year[5] - Total liabilities decreased to CNY 1,498,358,567.03 from CNY 1,516,206,671.97, a reduction of 1.2%[19] - The company reported a financial expense of CNY 12,263,056.41, which is a decrease of 24.6% from CNY 16,270,060.42 in the previous period[21] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 10,037, with the largest shareholder holding 30.43% of the shares[12] - A share transfer agreement has been signed to transfer 46,608,397 shares, representing 29.99% of the total share capital, from existing shareholders to Fujian Zongteng Network Co., Ltd.[15] - The control of the company will change from Shanghai Kangyi Investment Co., Ltd. to Fujian Zongteng Network Co., Ltd. after the share transfer is completed[15] - The major shareholders involved in the share transfer do not have any known relationships or agreements among themselves[15] Business Operations and Future Outlook - The company plans to sell assets related to its photovoltaic film business, with the transaction price yet to be determined pending asset evaluation[16] - The asset transfer agreement requires approval from the board and shareholders before implementation, indicating uncertainty in the transaction[16] - The company has experienced significant uncertainty regarding its ability to continue as a going concern, as highlighted in recent audit reports[15] - The company is currently in discussions regarding the control change, which carries significant investment risks for stakeholders[15] Research and Development - Research and development expenses were CNY 7,603,451.73, slightly down from CNY 7,835,076.19, reflecting a decrease of 3.0%[21] Inventory and Operating Costs - Total operating costs amounted to CNY 167,385,044.46, down 11.2% from CNY 188,466,936.22 in the prior period[21] - Inventory increased to CNY 105,878,765.92, up 10.6% from CNY 95,713,633.87[19] - The company reported a significant increase in investment income of ¥892,827.25, compared to a loss of -¥62,958.88 in the previous year, marking a change of -1518.11%[9] - Cash received from government subsidies related to operating activities decreased by 93.81% to ¥1,158,140.81 from ¥18,700,481.99 in the previous year[10]